Bradley L. Campbell, President and CEO at AMICUS THERAPEUTICS, INC. (FOLD), sold 7,500 shares at $11.46 ($86K) on 2024-11-01, disclosed to the SEC on 2024-11-04.
Scheduled sale ($86k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| FOLD | SELL | 2025-12-17 | $1.7M | — | Filing → |
| FOLD | SELL | 2025-12-03 | $292K | — | Filing → |
| FOLD | SELL | 2025-11-26 | $293K | — | Filing → |